Title:
1,5-DIPHENYL-PYRROLIDIN-2-ONE COMPOUNDS AS CB-1 LIGANDS
Document Type and Number:
WIPO Patent Application WO/2009/131814
Kind Code:
A3
Abstract:
CB-1 receptor inverse agonist compounds of Formula and pharmaceutical compositions for the treatment of obesity or cognitive impairment associated with schizophrenia.
More Like This:
WO/2017/024968 | VINYL COMPOUNDS AS FGFR AND VEGFR INHIBITORS |
WO/2016/082713 | 2-AMINOPYRIMIDINE COMPOUND AND PHARMACEUTICAL COMPOSITION AND USE THEREOF |
WO/2006/101859 | PIPERIDINYL SUBSTITUTED CYCLOHEXANE-1,4-DIAMINES |
Inventors:
HU JINGDAN (US)
Application Number:
PCT/US2009/039254
Publication Date:
October 20, 2011
Filing Date:
April 02, 2009
Export Citation:
Assignee:
LILLY CO ELI (US)
HU JINGDAN (US)
HU JINGDAN (US)
International Classes:
C07D401/02
Domestic Patent References:
WO2007020502A2 | 2007-02-22 | |||
WO2008070306A2 | 2008-06-12 | |||
WO2008070305A2 | 2008-06-12 |
Attorney, Agent or Firm:
TUCKER, R., Craig et al. (Patent DivisionP. O. Box 628, Indianapolis IN, US)
Download PDF:
Previous Patent: SURGICAL INSTRUMENT WITH INTERNAL IRRIGATION
Next Patent: MULTI-FUNCTIONAL PATIENT TRANSFER DEVICE
Next Patent: MULTI-FUNCTIONAL PATIENT TRANSFER DEVICE